Literature DB >> 24859765

Epigenetic repression of HOXB cluster in oral cancer cell lines.

Flávia Caló Aquino Xavier1, Maria Fernanda de Souza Setubal Destro2, Carina Magalhães Esteves Duarte2, Fabio Daumas Nunes3.   

Abstract

OBJECTIVE: Aberrant DNA methylation is a fundamental transcriptional control mechanism in carcinogenesis. The expression of homeobox genes is usually controlled by an epigenetic mechanism, such as the methylation of CpG islands in the promoter region. The aim of this study was to describe the differential methylation pattern of HOX genes in oral squamous cell carcinoma (OSCC) cell lines and transcript status in a group of hypermethylated and hypomethylated genes.
DESIGN: Quantitative analysis of DNA methylation was performed on two OSCC cell lines (SCC4 and SCC9) using a method denominated Human Homeobox Genes EpiTect Methyl qPCR Arrays, which allowed fast, precise methylation detection of 24 HOX specific genes without bisulfite conversion.
RESULTS: Methylation greater than 50% was detected in HOXA11, HOXA6, HOXA7, HOXA9, HOXB1, HOXB2, HOXB3, HOXB4, HOXB5, HOXB6, HOXC8 and HOXD10. Both cell lines demonstrated similar hypermethylation status for eight HOX genes. A similar pattern of promoter hypermethylation and hypomethylation was demonstrated for the HOXB cluster and HOXA cluster, respectively. Moreover, the hypermethylation profile of the HOXB cluster, especially HOXB4, was correlated with decreased transcript expression, which was restored following treatment with 5-aza-2'-deoxycytidine.
CONCLUSIONS: The homeobox methylation profile in OSCC cell lines is consistent with an epigenetic biomarker.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  DNA methylation; Epigenetics; HOX genes; Oral cancer

Mesh:

Substances:

Year:  2014        PMID: 24859765     DOI: 10.1016/j.archoralbio.2014.05.001

Source DB:  PubMed          Journal:  Arch Oral Biol        ISSN: 0003-9969            Impact factor:   2.633


  12 in total

1.  Comprehensive bioinformatics analyses identified Homeobox B9 as a potential prognostic biomarker and therapeutic target for gastric cancer.

Authors:  Xiaofei Li; Shujia Chen; Yinghui Zhu; Jiayue Fei; Liaoyuan Song; Guoyan Sun; Wei Niu; Lianyi Guo; Jiwei Wang
Journal:  J Gastrointest Oncol       Date:  2021-10

2.  Identification of HOX signatures contributing to oral cancer phenotype.

Authors:  Kanaka Sai Ram Padam; Richard Morgan; Keith Hunter; Sanjiban Chakrabarty; Naveena A N Kumar; Raghu Radhakrishnan
Journal:  Sci Rep       Date:  2022-06-16       Impact factor: 4.996

3.  Genome-wide screening of DNA methylation associated with lymph node metastasis in esophageal squamous cell carcinoma.

Authors:  Hiroaki Nagata; Ken-Ichi Kozaki; Tomoki Muramatsu; Hidekazu Hiramoto; Kousuke Tanimoto; Naoto Fujiwara; Seiya Imoto; Daisuke Ichikawa; Eigo Otsuji; Satoru Miyano; Tatsuyuki Kawano; Johji Inazawa
Journal:  Oncotarget       Date:  2017-06-06

4.  Combination of RERG and ZNF671 methylation rates in circulating cell-free DNA: A novel biomarker for screening of nasopharyngeal carcinoma.

Authors:  Yifei Xu; Weilin Zhao; Yingxi Mo; Ning Ma; Kaoru Midorikawa; Hatasu Kobayashi; Yusuke Hiraku; Shinji Oikawa; Zhe Zhang; Guangwu Huang; Kazuhiko Takeuchi; Mariko Murata
Journal:  Cancer Sci       Date:  2020-05-19       Impact factor: 6.716

Review 5.  Exploring the Role of Fallopian Ciliated Cells in the Pathogenesis of High-Grade Serous Ovarian Cancer.

Authors:  Michela Coan; Gian Luca Rampioni Vinciguerra; Laura Cesaratto; Emanuela Gardenal; Riccardo Bianchet; Erik Dassi; Andrea Vecchione; Gustavo Baldassarre; Riccardo Spizzo; Milena Sabrina Nicoloso
Journal:  Int J Mol Sci       Date:  2018-08-24       Impact factor: 5.923

6.  Differential gene methylation and expression of HOX transcription factor family in orbitofacial neurofibroma.

Authors:  Antje Arnold; Eddie Luidy Imada; M Lisa Zhang; Deepak P Edward; Luigi Marchionni; Fausto J Rodriguez
Journal:  Acta Neuropathol Commun       Date:  2020-05-04       Impact factor: 7.801

7.  Oncogenic and tumor suppressor function of MEIS and associated factors.

Authors:  Birkan Gİrgİn; Medine KaradaĞ-Alpaslan; Fatih KocabaŞ
Journal:  Turk J Biol       Date:  2020-12-14

8.  A methylation-driven gene panel predicts survival in patients with colon cancer.

Authors:  Yaojun Peng; Jing Zhao; Fan Yin; Gaowa Sharen; Qiyan Wu; Qi Chen; Xiaoxuan Sun; Juan Yang; Huan Wang; Dong Zhang
Journal:  FEBS Open Bio       Date:  2021-07-28       Impact factor: 2.693

9.  Seven-CpG-based prognostic signature coupled with gene expression predicts survival of oral squamous cell carcinoma.

Authors:  David C Christiani; Sipeng Shen; Guanrong Wang; Qianwen Shi; Ruyang Zhang; Yang Zhao; Yongyue Wei; Feng Chen
Journal:  Clin Epigenetics       Date:  2017-08-24       Impact factor: 6.551

10.  Epigenetic inactivation of HOXD10 is associated with human colon cancer via inhibiting the RHOC/AKT/MAPK signaling pathway.

Authors:  Yu-Hong Yuan; Han-Yu Wang; Yu Lai; Wa Zhong; Wei-Ling Liang; Fu-de Yan; Zhong Yu; Jun-Kai Chen; Ying Lin
Journal:  Cell Commun Signal       Date:  2019-01-25       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.